Alec Machiels, Director at Apellis Pharmaceuticals, Inc. (APLS), sold 2,500 shares at $45.34 ($113K) on 2023-09-15, disclosed to the SEC on 2023-09-18.
Scheduled sale ($113k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.34 | 1,250 | $57K | 50.0% |
| 2 | $45.34 | 1,250 | $57K | 50.0% |
| Total | $45.34 avg | 2,500 | $113K | 100% |
| Filing → |
| APLS | SELL | 2023-09-19 | $56K | — | Filing → |
| APLS | SELL | 2023-07-18 | $162K | — | Filing → |
| APLS | SELL | 2023-06-21 | $221K | — | Filing → |